Location History:
- 1000 Berlin 33, DE (1997)
- Berlin, DE (2004)
Company Filing History:
2 out of 832,880 Years Active: 1997-2004
Title: Werner Reutter: Innovator in Recombinant Glycoproteins
Introduction
Werner Reutter is a distinguished inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant glycoproteins. With a total of 2 patents, his work has implications for medical advancements and therapeutic applications.
Latest Patents
Reutter's latest patents include innovative methods for producing recombinant glycoproteins that serve as crucial signaling substances in the human circulatory system. One of his notable inventions focuses on recombinant human glycoproteins, including differentiation factors and growth factors, which are essential for various biological processes. His work also encompasses novel thrombolytic agents and coagulation factors, which have the potential to improve treatment options for patients with blood-related disorders.
Career Highlights
Throughout his career, Werner Reutter has been at the forefront of research in glycoprotein technology. His inventions have paved the way for new pharmaceutical agents that utilize these glycoproteins, enhancing their therapeutic efficacy. His dedication to innovation in this field has established him as a key figure in biotechnology.
Collaborations
Reutter has collaborated with notable colleagues, including Rolf Nuck and Rudolf Tauber. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their shared field of research.
Conclusion
Werner Reutter's contributions to the field of recombinant glycoproteins highlight his role as a leading inventor in biotechnology. His innovative patents and collaborative efforts continue to influence medical research and therapeutic development.